Albumin in Cardiac Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

1,386

Participants

Timeline

Start Date

March 21, 2017

Primary Completion Date

April 13, 2020

Study Completion Date

November 4, 2020

Conditions
C.Surgical Procedure; Cardiac
Interventions
DRUG

Albumin solution

"Albumin solution will used for priming of the CPB(cardio-pulmonary bypass) tubing. : A mixture of 20% (200 mg/mL) albumin (Albuman® 200 g/L, Sanquin, the Netherlands) with Ringer's acetate solution in the final albumin concentration of 4%.~During surgery and the first 24 hours of ICU treatment, albumin 4% solution will be used up to 3200 mL for volume replacement therapy. Ringer's acetate solution is used thereafter, i.e. if more than 3200 mL are needed for volume replacement therapy.The volume replacement therapy is not determined but will be based on the clinical decision."

DRUG

Ringers acetate solution

"The Ringers acetate solution will be used for priming of the CPB tubing. The CPB priming volume comprises only of Ringer´s solution.~During surgery and the first 24 hours of ICU treatment,Ringer´s acetate solution will be used up to 3200 mL for volume replacement therapy. Ringer's acetate solution is used thereafter, i.e. if more than 3200 mL are needed for volume replacement therapy during the second study phase. The volume replacement therapy is not determined but will be based on the clinical decision."

Trial Locations (1)

00029

Helsinki University Central Hospital, Meilahti Hospital, Helsinki

All Listed Sponsors
lead

Helsinki University Central Hospital

OTHER

NCT02560519 - Albumin in Cardiac Surgery | Biotech Hunter | Biotech Hunter